Physician profile
Charles E Padgett
NPI 1134189285
$5,719.47
in general payments reported to CMS, 2019-2025
37 companies · $759 in 2025
The $759 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,768 · 2020: $293 · 2021: $651 · 2022: $613 · 2023: $1,092 · 2024: $543 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,722 · Travel and Lodging: $538 · Education: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,721.52 |
| Travel and Lodging | $537.73 |
| Education | $135.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,011.17 | 2019 | |
| Astellas Pharma US INC | $628.12 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $602.45 | 2019-2024 | |
| Pfizer INC. | $570.80 | 2019-2024 | |
| Intuitive Surgical, INC. | $567.94 | 2023-2024 | Da Vinci Surgical System |
| Amgen INC. | $318.33 | 2019-2025 | Evenity, Prolia, Prolia |
| Avanos Medical | $216.36 | 2019 | |
| Mayne Pharma Commercial LLC | $168.02 | 2021-2025 | |
| Avion Pharmaceuticals | $165.54 | 2019-2022 | |
| Ethicon US, LLC | $134.48 | 2019-2022 | |
| Vertical Pharmaceuticals, LLC | $101.14 | 2019-2020 | |
| Hologic Sales and Service, LLC | $92.47 | 2019-2024 | Myosure Tissue Removal Device, Omni Hysteroscope |
| Therapeuticsmd, INC. | $89.48 | 2020-2022 | |
| Biom'Up France Sas | $88.22 | 2020-2021 | |
| Sage Therapeutics, LLC | $83.50 | 2024-2025 | Zurzuvae |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $83.41 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Shield Therapeutics INC | $76.03 | 2025 | |
| Shockwave Medical, INC | $72.14 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Mylan Pharmaceuticals INC. | $69.89 | 2020-2022 | |
| Biom'Up Sa | $69.22 | 2019 | |
| Exeltis, USA INC. | $68.96 | 2019-2023 | Slynd |
| Takeda Pharmaceuticals U.S.A., INC. | $51.88 | 2022 | |
| Coopersurgical, INC. | $49.30 | 2025 | Ally II Ups |
| Dexcom, INC. | $44.16 | 2025 | Dexcom G6 Transmitter |
| Organon LLC | $36.96 | 2022-2024 | Jada System |
| Sumitomo Pharma America, INC. | $35.62 | 2024 | Myfembree |
| Lilly USA, LLC | $32.55 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $29.73 | 2024 | Quviviq |
| Xeris Pharmaceuticals, INC. | $24.28 | 2022 | |
| Solventum Corporation | $22.30 | 2025 | V.A.C.Ulta |
| Pacira Pharmaceuticals Incorporated | $20.41 | 2025 | Exparel |
| Becton, Dickinson and Company | $20.00 | 2025 | Bd Onclarity |
| Scynexis, INC. | $18.93 | 2022 | |
| Myovant Sciences INC. | $17.30 | 2021 | |
| Lupin INC. | $15.45 | 2020 | |
| Evofem Biosciences, INC. | $11.55 | 2021 | |
| Roche Diagnostics Corporation | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Padgett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.